Filing Details
- Accession Number:
- 0001209191-21-014002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-24 19:37:29
- Reporting Period:
- 2021-02-22
- Accepted Time:
- 2021-02-24 19:37:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1490978 | Schrodinger Inc. | SDGR | Pharmaceutical Preparations (2834) | 954284541 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1797725 | Jennifer Daniel | C/O Schrodinger, Inc., 120 West 45Th Street, 17Th Floor New York NY 10036 | Svp & Chief Hr Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-22 | 3,344 | $3.07 | 10,032 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-22 | 3,344 | $111.22 | 6,688 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-02-23 | 3,344 | $3.07 | 10,032 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-23 | 3,344 | $106.70 | 6,688 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-22 | 3,344 | $0.00 | 3,344 | $3.07 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-23 | 3,344 | $0.00 | 3,344 | $3.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,378 | 2027-04-07 | No | 4 | M | Direct | |
10,034 | 2027-04-07 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
- This option was granted on April 7, 2017 and is fully vested.